A New Gene Editing Technique Turns Human Pluripotent Stem Cells Into a Model System for Polycystic Kidney Disease
Friday, December 11, 2015 - 11:53
in Biology & Nature
By linking CRISPR/Cas9 with another cutting edge technology--human pluripotent stem cells (hPSCs). Benjamin. Freedman, now at the University of Washington, and his colleagues in Joseph Bonventre's lab at Harvard Medical School, have used CRISPR/Cas9 to guide hPSCs into becoming a human cell-based lab model system for polycystic kidney disease (PKD).